Literature DB >> 31698414

PET-adapted treatment of Hodgkin lymphoma.

Martin Hutchings.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31698414     DOI： 10.1182/blood.2019002420

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

Review 1.  Emerging Therapies in Relapsed and Refractory Hodgkin Lymphoma: What Comes Next After Brentuximab Vedotin and PD-1 Inhibition?

Authors:  Tamer Othman; Alex Herrera; Matthew Mei
Journal:  Curr Hematol Malig Rep       Date:  2021-01-06       Impact factor: 3.952

2.  Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.

Authors:  Musa Alzahrani; Mubarak M Al-Mansour; John Apostolidis; Ahmed Barefah; Reyad Dada; Ayman Alhejazi; Yasir Alayed; Ibraheem Motabi; Mansoor Radwi; Hani Al-Hashmi
Journal:  Saudi J Med Med Sci       Date:  2020-08-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.